




Instance: composition-en-c8b09940edf0aa917a934cf86ca85bbd
InstanceOf: CompositionUvEpi
Title: "Composition for spherox Package Leaflet"
Description:  "Composition for spherox Package Leaflet"
Usage: #inline

* identifier.system = "http://ema.europa.eu/identifier"

* identifier.value = "identifier"
* status = #final

* type = https://spor.ema.europa.eu/rmswi/#100000155538
* type.text = "Package Leaflet"

* subject = Reference(mpcc2920aecc48b5afdbce13ee59b0282a)
* date = "2022-02-16T13:28:17Z"

 

 // Reference to Organization: MAH
* author = Reference(mah-ema)


* title = "TEST PURPOSES ONLY - spherox"
* attester.mode = http://hl7.org/fhir/composition-attestation-mode#official
* attester.time =  "2022-02-16T13:28:17Z"
* language = #en
* category = epicategory-cs#R "Raw"


* section[+].
  * title = "B. Package Leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "B. Package Leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   


      
* section[=].section[+]
  * title = "Package leaflet: Information for the user"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "Package leaflet: Information for the user"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   



* section[=].section[+]
  * title = "What is in this leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "What is in this leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>What is in this leaflet</p>
<ol>
<li>What Spherox is and what it is used for </li>
<li>What you need to know before you are given Spherox </li>
<li>How to use Spherox </li>
<li>Possible side effects </li>
<li>How to store Spherox </li>
<li>Contents of the pack and other information </li>
</ol>         </div>"""   
          

* section[=].section[+]
  * title =  "1. What spherox is and what it is used for"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text =  "1. What spherox is and what it is used for"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Spherox is a medicine used to repair damage to the cartilage of the knee in adults and in 
adolescents whose bones in the joint have finished growing. Cartilage is a hard smooth layer inside 
your joints, on the ends of the bones. It protects the bones and allows joints to work smoothly. 
Spherox is used in adults, or adolescents whose bones have finished growing, when the cartilage in the 
knee joint is damaged, for example by acute injury, such as a fall or long-term wear due to incorrect 
weight bearing on the joint. Spherox is used to treat defects up to 10 cm  in size. </p>
<p>Spherox consists of so-called spheroids. A spheroid looks like a tiny pearl made of cartilage cells and 
cartilage material derived from your own body. To make the spheroids, a small cartilage sample is 
taken from one of your joints during a minor operation, and then grown in the laboratory to make the 
medicine. The spheroids are implanted by surgery to the damaged cartilage area and stick to the 
damaged part. They are then expected to repair the damage with healthy and functional cartilage over 
time. </p>         </div>"""   
          

             
* section[=].section[+]
  * title = "2. What you need to know before you take spherox"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "2. What you need to know before you take spherox"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Do not use Spherox if  </p>
<ul>
<li>the bones in the knee joint have not finished growing </li>
<li>you have advanced joint and bone inflammation with damage in the affected joint 
(osteoarthritis) </li>
<li>you are infected with HIV (the virus that causes AIDS), hepatitis B virus or hepatitis C virus </li>
</ul>
<p>Warnings and precautions </p>
<p>Talk to your doctor before you are given Spherox, if you have any other joint problems or excess 
weight, as this may reduce the success of the procedure. </p>
<p>Spherox should preferably be implanted into an otherwise healthy joint. Other joint problems should 
be corrected before or at the time of Spherox implantation. </p>
<p>After the treatment, bleeding into the knee joint and possibly into the surrounding area may happen, 
mainly if you have an increased tendency of bleeding or if bleeding during the treatment could not be 
fully stopped. The physician will check in advance the risk that you may face a bleeding after the 
treatment. In that case, you will get medicine to decrease the risk of bleeding after the treatment. </p>
<p>Rehabilitation program </p>
<p>Follow the rehabilitation program strictly after implantation. Only resume physical activity when 
instructed by your doctor. Resuming vigorous activity too soon may reduce the benefit and durability 
of Spherox. </p>
<p>Other cases in which Spherox cannot be supplied </p>
<p>Even if the cartilage sample has already been taken, it may happen that you cannot be treated with 
Spherox. This can occur because the sample taken is not of sufficient quality to manufacture the 
product. Your doctor might have to select an alternative treatment for you. </p>
<p>Children and adolescents </p>
<p>Spherox shall not be used in children or adolescents whose bones in the knee joint have not finished 
growing. </p>
<p>Other medicines and Spherox </p>
<p>Tell your doctor if you are using, have recently used or might use any other medicines. </p>
<p>Pregnancy and breast-feeding  </p>
<p>Spherox is not recommended for pregnant or breast-feeding women, as it is applied during surgery. If 
you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask 
your doctor for advice before using this medicine. </p>
<p>Driving and using machines </p>
<p>The surgical procedure to implant this medicine will have a major influence on your ability to drive 
and use machines. Driving cars and using machines may be limited during the rehabilitation period. 
Strictly follow the advice of your doctor or physical therapist. </p>         </div>"""   
                    
* section[=].section[+]
  * title =  "3. How to take spherox"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "3. How to take spherox"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Spherox can only be implanted by a specialist doctor in a medical facility and must only be used in the 
patient for whom it has been prepared. </p>
<p>Treatment with Spherox is a two-step procedure: </p>
<p>Visit 1: 
Evaluation of the damage to the cartilage, sample and blood taking </p>
<p>On the first visit, the doctor will examine the damage to your knee cartilage during an exploratory 
operation. This is usually done as keyhole surgery through very small incisions (cuts), using a special 
instrument to look inside the knee (arthroscopy). 
If Spherox is appropriate for you, the doctor will take a small cartilage sample from your joint. Most 
likely this will be from the same knee joint that has to be treated. Your cartilage cells are extracted 
from this sample in a laboratory and are then grown to make the spheroids that constitute Spherox. 
The process takes about 6 to 8 weeks. </p>
<p>Visit 2: 
Spherox implantation </p>
<p>Spherox is implanted into the damaged area of cartilage in the knee during a second operation. This 
may also be carried out by keyhole surgery.  </p>
<p>Rehabilitation </p>
<p>In order to allow your knee joint to recover well, you will have to follow an individual rehabilitation 
program. This may take up to one year. Your doctor or physical therapist will advise you. </p>
<p>Very important: Carefully follow the recommendations of your doctor and physical therapist. The 
risk of treatment failure may increase if you do not follow your rehabilitation schedule. 
Be very careful when bending and putting weight on your treated joint. During the rehabilitation 
period, the amount of weight you can put on the joint will increase gradually. How quickly this occurs 
depends for example on your body weight and the extent of the damage to the cartilage. Depending on 
the condition of the treated knee joint, you may have to wear a brace. </p>
<p>Ask your doctor or physical therapist if you have any further questions about treatment with Spherox. </p>         </div>"""         

        
* section[=].section[+]
  * title = "4. Possible side effects"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "4. Possible side effects"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Like all medicines, this medicine can cause side effects, although not everybody gets them. Side 
effects appearing after the implantation of Spherox are mostly related to the surgery. The recorded side 
effects, either caused by the medicine or the surgery, were in most cases not serious. </p>
<p>If you get any of the following serious side effects, you should immediately contact a doctor: </p>
<ul>
<li>hypersensitivity (allergy) (one or more of the following symptoms may occur: skin redness, 
swelling in the treated area, low blood pressure, difficulties to breathe, swollen tongue or throat, 
weak and rapid pulse, sickness, vomiting, diarrhoea, dizziness, fainting, fever) </li>
<li>blood clot in a vein (one or more of the following symptoms may occur: swelling in the leg, 
pain, increased warmth in the leg) </li>
</ul>
<p>Other side effects  </p>
<p>Side effects can occur with the following frequencies: 
Common: may affect up to 1 in 10 people 
* accumulation of fluid in the knee 
* pain in the knee 
* swelling in the knee 
* accumulation of excess fluid in the bone marrow 
* pain </p>
<p>Uncommon: may affect up to 1 in 100 people 
* increase in size of the cartilage cells, softening of cartilage. You may notice symptoms, for 
example swelling or pain of the tissues around the knee. 
* cracking sounds in the knee 
* joint lock in the knee 
* impairment of walking 
* tissue lump that may occur in the knee, fragment of cartilage or bone that freely floats in the 
knee joint space. You may notice symptoms, for example a painless heavy swelling of the 
treated knee, sudden pain or problems to move the treated knee. 
* cartilage cells in Spherox do not survive and grow 
* any damage of knee cartilage 
* ligament disorder 
* tendon inflammation 
* muscle weakness 
* pain in the front of the knee or kneecap 
* swelling of the treated leg due to obstructed flow of tissue fluid via the lymph vessels 
* scar tissue pain 
* blockage of a blood vessel in the lung 
* inflammation of the inner layer of the joint capsule </p>
<p>Rare: may affect up to 1 in 1000 people 
* disorder of bone formation, death of bone tissue, bone formation outside the skeleton. You may 
notice symptoms, for example swelling or pain of the tissues around the knee. 
* infection at the site of implantation 
* inflammation of the knee joint caused by bacteria or fungi 
* partial or complete detachment of the tissue beneath the bone and surrounding cartilage 
* inflammation of the bone marrow caused by bacteria or fungi 
* inflammation of the skin and/or the soft tissue caused by bacteria or fungi 
* pain below the kneecap due to inflammation of the soft tissue 
* inflammation of veins combined with the formation of a blood clot located near the surface of 
the skin (symptoms: e.g. redness and/or warmth of the skin along the vein, tenderness, pain) 
* healing complication in the area of treatment 
* reopening of a closed wound 
* bruising </p>
<p>Very rare: may affect up to 1 in 10.000 people 
* discomfort </p>
<p>Not known: frequency cannot be determined 
* excessive scar tissue formation within the knee joint and/or surrounding of soft tissues 
* infection of the lungs </p>
<p>Reporting side effects </p>
<p>If you get any side effects, talk to your doctor or physical therapist. This includes any possible side 
effects not listed in this leaflet. You can also report side effects directly via the national reporting 
system listed in Appendix V. By reporting side effects you can help provide more information on the 
safety of this medicine. </p>         </div>"""      
        
* section[=].section[+]
  * title = "5. How to store spherox"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "5. How to store spherox"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>This product will be carefully stored by medical staff in the hospital where the medicine will be given 
to you, and the storage instruction for them are as follow: </p>
<p>Do not use this medicine after the expiry date which is stated on the label after EXP. 
Store and transport refrigerated (1  C to 10  C). 
Do not freeze. Do not irradiate. 
Do not open the outer packaging before use to prevent microbial contamination. </p>         </div>"""      
        
        
* section[=].section[+]
  * title = "6. Contents of the pack and other information"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "6. Contents of the pack and other information"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>What Spherox contains  </p>
<ul>
<li>The active substance of Spherox are spheroids that consist of cartilage cells and cartilage 
material derived from your own body. 
Spherox contains 10-70 spheroids per cm  of the cartilage defect. </li>
<li>The other ingredient is sodium chloride used as transport solution. </li>
</ul>
<p>What Spherox looks like and contents of the pack </p>
<p>Implantation suspension. </p>
<p>Spherox contains so-called spheroids that consist of living cartilage cells with a non-cellular portion 
for the repair of cartilage defects. The spheroids look like small white to yellowish pearls. They are 
transported in a clear colourless solution. Spherox is delivered to the doctor in a container ready for 
application. The container may be a syringe or a special application system called co.fix that is a 
catheter (narrow tube) with a stem length of 150 mm. 
The applicator co.fix 150 is packed in a sterile tube and additionally surrounded by an extra bag. 
The pre-filled syringe is packed in a sterile tube and additionally surrounded by an extra bag. </p>
<p>Marketing Authorisation Holder  </p>
<p>CO.DON GmbH<br />
Deutscher Platz 5d 
04103 Leipzig, Germany 
Tel.: +49 341 99190 Fax: +49 341 99190 E-mail: info@codon.de </p>
<p>Manufacturer </p>
<p>CO.DON GmbH 
Warthestra e 14513 Teltow, Germany </p>
<p>CO.DON GmbH 
Deutscher Platz 5d 
04103 Leipzig, Germany </p>
<p>This leaflet was last revised in </p>
<p>Detailed information on this medicine is available on the European Medicines Agency web site: </p>         </div>"""      



Instance: composition-da-c8b09940edf0aa917a934cf86ca85bbd
InstanceOf: CompositionUvEpi
Title: "Composition for spherox Package Leaflet"
Description:  "Composition for spherox Package Leaflet"
Usage: #inline

* identifier.system = "http://ema.europa.eu/identifier"

* identifier.value = "identifier"
* status = #final

* type = https://spor.ema.europa.eu/rmswi/#100000155538
* type.text = "Package Leaflet"

* subject = Reference(mpcc2920aecc48b5afdbce13ee59b0282a)
* date = "2022-02-16T13:28:17Z"

 

 // Reference to Organization: MAH
* author = Reference(mah-ema)


* title = "TEST PURPOSES ONLY - spherox"
* attester.mode = http://hl7.org/fhir/composition-attestation-mode#official
* attester.time =  "2022-02-16T13:28:17Z"
* language = #da
* category = epicategory-cs#R "Raw"


* section[+].
  * title = "B. Package Leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "B. Package Leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   


      
* section[=].section[+]
  * title = "Package leaflet: Information for the user"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "Package leaflet: Information for the user"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   



* section[=].section[+]
  * title = "What is in this leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "What is in this leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Oversigt over indlægssedlen </p>
<ol>
<li>Virkning og anvendelse </li>
<li>Det skal du vide, før du får Spherox </li>
<li>Sådan skal du bruge Spherox </li>
<li>Bivirkninger </li>
<li>Opbevaring </li>
<li>Pakningsstørrelser og yderligere oplysninger </li>
</ol>         </div>"""   
          

* section[=].section[+]
  * title =  "1. What spherox is and what it is used for"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text =  "1. What spherox is and what it is used for"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Spherox er et lægemiddel, der anvendes til at reparere skader på brusken i knæet hos voksne og 
unge, hvor knoglerne i leddet er udvoksede. Brusk er et hårdt, glat lag i leddene, på knoglernes 
endeflade. Det beskytter knoglerne og gør, at vores led arbejder gnidningsfrit. Spherox anvendes til 
voksne eller unge, hvis knogler er udvoksede, når brusken i knæleddet er beskadiget, for eksempel af 
en akut skade, såsom et fald, eller slitage som følge af langvarig forkert vægtbelastning af leddet. 
Spherox anvendes til at behandle defekter op til 10 cm² i areal.  </p>
<p>Spherox består af såkaldte sfæroider. En sfæroide ligner en lille perle og er dannet af bruskceller og 
bruskmateriale fra din egen krop. For at fremstille sfæroiderne tages et lille stykke brusk fra et af dine 
led ved et lille indgreb. Det dyrkes derefter i laboratoriet for at fremstille lægemidlet. Sfæroiderne 
implanteres kirurgisk i det beskadigede bruskområde og sætter sig fast på den beskadigede del. De 
forventes efterhånden at reparere skaden med sund og velfungerende brusk. </p>         </div>"""   
          

             
* section[=].section[+]
  * title = "2. What you need to know before you take spherox"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "2. What you need to know before you take spherox"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Brug ikke Spherox  </p>
<ul>
<li>
<p>hvis knoglerne i knæleddet ikke er udvoksede </p>
</li>
<li>
<p>hvis du har fremskreden betændelse af led og knogler med beskadigelse af det berørte led 
(slidgigt) </p>
</li>
<li>
<p>hvis du er smittet med HIV (virusset der er årsag til AIDS), hepatitis B-virus eller hepatitis C-
virus </p>
</li>
</ul>
<p>Advarsler og forsigtighedsregler </p>
<p>Tal med lægen, før du får Spherox, hvis du har andre ledproblemer eller er overvægtig, da det kan 
bevirke, at resultatet bliver mindre vellykket. </p>
<p>Spherox bør fortrinsvis implanteres i et ellers raskt led. Andre ledproblemer bør rettes før implantation 
af Spherox eller på tidspunktet for implantationen. </p>
<p>Efter behandlingen kan der forekomme blødning i knæleddet og muligvis i det omkringliggende 
område, især hvis du har en øget tendens til blødning, eller hvis blødningen under behandlingen ikke 
kunne stoppes helt. Lægen vil i forvejen kontrollere risikoen for, om du kan opleve en blødning efter 
behandlingen. Hvis det er tilfældet, vil du få medicin til at sænke blødningsrisikoen efter 
behandlingen. </p>
<p>Rehabiliteringsprogram </p>
<p>Følg rehabiliteringsprogrammet nøje efter implantationen. Genoptag ikke fysisk aktivitet, før lægen 
instruerer dig om det. For tidlig genoptagelse af fysisk aktivitet kan nedsætte fordelen ved Spherox 
og bevirke, at behandlingen ikke virker så længe. </p>
<p>Andre tilfælde, hvor Spherox ikke kan leveres </p>
<p>Selv om du allerede har fået udtaget et stykke brusk, kan det ske, at du ikke kan behandles med 
Spherox. Dette kan skyldes, at den udtagne brusk ikke er af tilstrækkelig kvalitet til at produktet kan 
fremstilles. Lægen kan være nødt til at vælge en anden behandling til dig. </p>
<p>Børn og unge </p>
<p>Spherox må ikke anvendes til børn eller unge, hvor knoglerne i leddet ikke er udvoksede. </p>
<p>Brug af anden medicin sammen med Spherox </p>
<p>Fortæl det altid til lægen, hvis du bruger anden medicin, for nylig har brugt anden medicin eller 
planlægger at bruge anden medicin. </p>
<p>Graviditet og amning  </p>
<p>Anvendelse af Spherox frarådes til gravide eller ammende kvinder, da det anvendes ved operation. 
Hvis du er gravid eller ammer, har mistanke om, at du er gravid, eller planlægger at blive gravid, skal 
du spørge din læge til råds, før du bruger dette lægemiddel. </p>
<p>Trafik- og arbejdssikkerhed </p>
<p>Operationen for at implantere dette lægemiddel vil i væsentlig grad påvirke din evne til at føre 
motorkøretøj og betjene maskiner. Din mulighed for at føre motorkøretøj og betjene maskiner kan 
være begrænset i rehabiliteringsperioden. Følg nøje anvisningerne fra lægen eller fysioterapeuten. </p>         </div>"""   
                    
* section[=].section[+]
  * title =  "3. How to take spherox"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "3. How to take spherox"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Spherox kan kun implanteres af en speciallæge på en klinik og må kun anvendes hos den patient, som 
det er fremstillet til. </p>
<p>Behandling med Spherox sker i to trin: </p>
<p>Besøg 1: 
Vurdering af beskadigelsen af brusken, prøvetagning og blodprøvetagning </p>
<p>Ved det første besøg vil lægen undersøge beskadigelsen af brusken i dit knæ ved en undersøgende 
operation. Dette gøres normalt ved en kikkertoperation gennem meget små snit ved hjælp af et særligt 
instrument, der giver mulighed for at se ind i knæet (artroskopi). 
Hvis Spherox er egnet til dig, vil lægen tage en lille bruskprøve fra dit led. Det vil mest sandsynligt 
være fra det samme knæled, som skal behandles. Fra denne prøve ekstraheres dine bruskceller i 
laboratoriet og dyrkes derefter til fremstilling af de sfæroider, som Spherox består af. Denne proces 
varer 6-8 uger. </p>
<p>Besøg 2: 
Implantation af Spherox </p>
<p>Ved en til operation implanteres Spherox i området med det beskadigede brusk i knæet. Dette kan 
ligeledes udføres ved en kikkertoperation.  </p>
<p>Rehabilitering </p>
<p>For at dit knæled kan komme sig godt, skal du følge et individuelt rehabiliteringsprogram. Dette kan 
vare op til et år. Det får du besked om af lægen eller fysioterapeuten. </p>
<p>Meget vigtigt: Følg nøje lægens og fysioterapeutens anvisninger. Hvis du ikke følger 
rehabiliteringsplanen, er der større risiko for, at behandlingen mislykkes. 
Vær meget forsigtig, når du bøjer og belaster det behandlede led. I løbet af rehabiliteringsperioden kan 
du efterhånden belaste leddet mere og mere. Hvor hurtigt dette går, afhænger f.eks. af din vægt og 
omfanget af beskadigelsen af brusken. Afhængigt af tilstanden af det behandlede knæled skal du 
muligvis have en skinne på. </p>
<p>Spørg lægen eller fysioterapeuten, hvis du har flere spørgsmål om behandling med Spherox. </p>         </div>"""         

        
* section[=].section[+]
  * title = "4. Possible side effects"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "4. Possible side effects"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Dette lægemiddel kan som alle andre lægemidler give bivirkninger, men ikke alle får bivirkninger. 
Bivirkningerne efter implantation af Spherox skyldes hovedsagelig operationen. Disse registrerede 
bivirkninger, enten forårsaget af lægemidlet eller operationen, var i de fleste tilfælde ikke alvorlige. </p>
<p>Hvis du får nogen af følgende alvorlige bivirkninger, skal du straks kontakte din læge: </p>
<ul>
<li>
<p>allergi (hypersensitivitet) (en eller flere af følgende symptomer kan forekomme: hudrødme, 
hævelse af det behandlede område, lavt blodtryk, vejrtrækningsbesvær, hævet tunge eller hals, 
svag, hurtig puls, kvalme, opkastning, diarré, svimmelhed, besvimelse og feber) </p>
</li>
<li>
<p>blodprop i en vene (en eller flere af følgende symptomer kan forekomme: hævelse i benet, 
smerter og varmefornemmelse i benet) </p>
</li>
</ul>
<p>Andre bivirkninger  </p>
<p>Bivirkningerne kan optræde med følgende hyppigheder: 
Almindelig: (kan forekomme hos op til 1 ud af 10 personer) </p>
<ul>
<li>
<p>væskeansamling i knæet </p>
</li>
<li>
<p>knæsmerter </p>
</li>
<li>
<p>hævelse af knæet </p>
</li>
<li>
<p>ophobning af overskydende væske i knoglemarven </p>
</li>
<li>
<p>smerter. </p>
</li>
</ul>
<p>Ikke almindelig: (kan forekomme hos op til 1 ud af 100 personer) </p>
<ul>
<li>
<p>øget størrelse af bruskcellerne, opblødning af brusken. Du kan bemærke symptomer, for 
eksempel hævelse eller smerter i vævet rundt om knæet. </p>
</li>
<li>
<p>knirkende lyde i knæet </p>
</li>
<li>
<p>låsning af knæet </p>
</li>
<li>
<p>gangbesvær </p>
</li>
<li>
<p>der kan forekomme en klump af væv i knæet, fragment af brusk eller knogle, der flyder frit 
rundt i knæleddet. Du kan bemærke symptomer, for eksempel en smertefri stor hævelse af det 
behandlede knæ, pludselige smerter eller problemer med at bevæge det behandlede knæ. </p>
</li>
<li>
<p>bruskcellerne i Spherox overlever ikke, så de vokser ikke </p>
</li>
<li>
<p>alle former for skader på brusken i knæet </p>
</li>
<li>
<p>ledbåndslidelse </p>
</li>
<li>
<p>senebetændelse </p>
</li>
<li>
<p>muskelsvaghed </p>
</li>
<li>
<p>smerter forrest i knæet eller i knæskallen </p>
</li>
<li>
<p>hævelse af det behandlede ben som følge af blokering af gennemstrømningen af vævsvæske via 
lymfekarrene  </p>
</li>
<li>
<p>smerter i arvæv </p>
</li>
<li>
<p>blokering af et blodkar i lungen </p>
</li>
<li>
<p>betændelse af det indre lag af ledkapslen </p>
</li>
</ul>
<p>Sjælden: (kan forekomme hos op til 1 ud af 1.000 personer): </p>
<ul>
<li>
<p>forstyrrelse af knogledannelsen, knoglevævsdød, knogledannelse udenfor skelettet. Du kan 
bemærke symptomer, for eksempel hævelse eller smerter i vævet rundt om knæet. </p>
</li>
<li>
<p>infektion på implantationsstedet </p>
</li>
<li>
<p>betændelse i knæleddet forårsaget af bakterier eller svampe </p>
</li>
<li>
<p>hel eller delvis løsning af vævet under knoglen og den omgivende brusk </p>
</li>
<li>
<p>betændelse i knoglemarven forårsaget af bakterier eller svampe </p>
</li>
<li>
<p>betændelse i huden og/eller i blødvævet forårsaget af bakterier eller svampe </p>
</li>
<li>
<p>smerter under knæskallen forårsaget af betændelse i bløddele </p>
</li>
<li>
<p>inflammation (betændelseslignende reaktion) i vener i forbindelse med dannelse af en blodprop 
tæt på hudoverfladen (symptomer: f.eks. rødme og/eller varmefornemmelse i huden langs 
venen, ømhed og smerter) </p>
</li>
<li>
<p>helingskomplikationer på behandlingsområdet </p>
</li>
<li>
<p>genåbning af et lukket sår </p>
</li>
<li>
<p>blå mærker </p>
</li>
</ul>
<p>Meget sjælden: kan forekomme hos op til 1 ud af 10,000 personer </p>
<ul>
<li>utilpashed </li>
</ul>
<p>Ikke kendt: hyppigheden kan ikke bestemmes </p>
<ul>
<li>
<p>for kraftig dannelse af arvæv i knæleddet og/eller i det omgivende blødvæv </p>
</li>
<li>
<p>infektion i lungerne </p>
</li>
</ul>
<p>Indberetning af bivirkninger </p>
<p>Kontakt lægen eller fysioterapeuten, hvis du får bivirkninger, herunder bivirkninger, som ikke er 
nævnt her. Du kan desuden indberette bivirkninger direkte til Lægemiddelstyrelsen via det nationale 
indberetningssystem, der er anført i Appendiks V. Ved at indberette bivirkninger kan du hjælpe med at 
fremskaffe mere information om sikkerheden af dette lægemiddel. </p>         </div>"""      
        
* section[=].section[+]
  * title = "5. How to store spherox"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "5. How to store spherox"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Dette produkt vil blive opbevaret forsvarligt af det læger og sygeplejersker på hospitalet, hvor du vil få 
lægemidlet, og opbevaringsinstruktionerne for det er følgende: </p>
<p>Brug ikke lægemidlet efter den udløbsdato, der står på pakningen efter EXP. 
Opbevares og transporteres nedkølet (1 °C til 10 °C). 
Må ikke nedfryses. Må ikke bestråles. 
Undgå at åbne den ydre emballage før brug for at undgå mikrobiel kontaminering. </p>         </div>"""      
        
        
* section[=].section[+]
  * title = "6. Contents of the pack and other information"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "6. Contents of the pack and other information"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Spherox indeholder:  </p>
<ul>
<li>
<p>Det aktive stof i Spherox er sfæroider, der består af bruskceller og bruskmateriale udvundet fra 
din egen krop. 
Spherox indeholder 10-70 sfæroider pr cm² af bruskdefekten. </p>
</li>
<li>
<p>Det andet indholdsstof er natriumchlorid, der anvendes som transportvæske. </p>
</li>
</ul>
<p>Udseende og pakningsstørrelser </p>
<p>Suspension til implantation. </p>
<p>Spherox indeholder såkaldte sfæroider, der består af levende bruskceller med en ikkecellulær del til 
reparation af bruskdefekter. Sfæroiderne ligner små hvide til let gullige perler. De transporteres i en 
klar, farveløs opløsning. Spherox leveres til lægen i en beholder klar til anvendelse. Beholderen kan 
være en sprøjte eller et særligt påføringssystem, der kaldes co.fix, som er et kateter (snæver slange) 
med en skaftlængde på 150 mm. 
Applikatoren co.fix 150 er pakket i et sterilt rør og desuden beskyttet af en ekstra pose. 
Den fyldte sprøjte er pakket i et sterilt rør og desuden beskyttet af en ekstra pose. </p>
<p>Indehaver af markedsføringstilladelsen </p>
<p>CO.DON GmbH 
Deutscher Platz 5d, 
04103 Leipzig, Tyskland 
Tlf.: +49 341 99190 Fax: +49 341 99190 E-mail: info@codon.de </p>
<p>Fremstiller </p>
<p>CO.DON GmbH 
Warthestraße 14513 Teltow, Tyskland </p>
<p>CO.DON GmbH 
Deutscher Platz 5d 
04103 Leipzig, Tyskland </p>
<p>Denne indlægsseddel blev senest revideret </p>
<p>Du kan finde yderligere oplysninger om dette lægemiddel på Det Europæiske Lægemiddelagenturs 
hjemmeside: http://www.ema.europa.eu. </p>         </div>"""      





                    
Instance: bundlepackageleaflet-en-c8b09940edf0aa917a934cf86ca85bbd
InstanceOf: BundleUvEpi
Title: "ePI document Bundle for spherox Package Leaflet for language en"
Description: "ePI document Bundle for spherox Package Leaflet for language en"
Usage: #example


* identifier.system = "http://ema.europa.eu/identifier" 
* identifier.value = "None"
* type = #document
* timestamp = "2023-06-27T10:09:22Z"
* language = #en

// Composition
* entry[0].fullUrl = "Composition/composition-en-c8b09940edf0aa917a934cf86ca85bbd"
* entry[0].resource = composition-en-c8b09940edf0aa917a934cf86ca85bbd

// MPD
* entry[+].fullUrl = "MedicinalProductDefinition/mpc8b09940edf0aa917a934cf86ca85bbd"
* entry[=].resource = mpc8b09940edf0aa917a934cf86ca85bbd
                            
                    
Instance: bundlepackageleaflet-da-c8b09940edf0aa917a934cf86ca85bbd
InstanceOf: BundleUvEpi
Title: "ePI document Bundle for spherox Package Leaflet for language da"
Description: "ePI document Bundle for spherox Package Leaflet for language da"
Usage: #example


* identifier.system = "http://ema.europa.eu/identifier" 
* identifier.value = "None"
* type = #document
* timestamp = "2023-06-27T10:09:22Z"
* language = #da

// Composition
* entry[0].fullUrl = "Composition/composition-da-c8b09940edf0aa917a934cf86ca85bbd"
* entry[0].resource = composition-da-c8b09940edf0aa917a934cf86ca85bbd

// MPD
* entry[+].fullUrl = "MedicinalProductDefinition/mpc8b09940edf0aa917a934cf86ca85bbd"
* entry[=].resource = mpc8b09940edf0aa917a934cf86ca85bbd
                            
                    



Instance: mpc8b09940edf0aa917a934cf86ca85bbd
InstanceOf: MedicinalProductDefinitionUvEpi
Title: "Medicinal Product Spherox 10-70 spheroids/cm2 implantation suspension"
Description: "Spherox 10-70 spheroids/cm2 implantation suspension"
Usage: #inline

 
* identifier[+].system = "http://ema.europa.eu/identifier"
* identifier[=].value = "EU/1/17/1181/001"
* type = http://hl7.org/fhir/medicinal-product-type#MedicinalProduct "Medicinal Product"

* domain = http://hl7.org/fhir/medicinal-product-domain#Human "Human use"

* status = http://hl7.org/fhir/publication-status#active "active"



* legalStatusOfSupply = $spor-rms#100000072084 "Medicinal product subject to medical prescription"

* name
  * productName = "Spherox 10-70 spheroids/cm2 implantation suspension"
  * type = $spor-productNamePartType-cs#220000000001 "Full name" 
  
  * part[0]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000002 "Invented name part"
  
  * part[+]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000003 "Scientific name part"
  
  * part[+]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000004 "Strength part"
  
  * part[+]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000005 "Pharmaceutical dose form part"
  
  * usage
    * country = urn:iso:std:iso:3166#EU "EU"
    * jurisdiction = urn:iso:std:iso:3166#EU "EU"
    * language = urn:ietf:bcp:47#en  "en"



RuleSet: c8b09940edf0aa917a934cf86ca85bbdListRuleset

* identifier.system = "http://ema.europa.eu/identifier" 
* identifier.value = "None"
* identifier[+].system = "http://spor.ema.europa.eu/v2/medicine-name"
* identifier[=].value = "spherox"

* status = #current
* mode = #working

* title = "List of all ePIs associated with spherox"

* subject = Reference(mpcc2920aecc48b5afdbce13ee59b0282a)
* subject.extension[0].url = "http://ema.europa.eu/fhir/extension/medicine-name"
* subject.extension[=].valueCoding = $100000000005#spherox "spherox"
* subject.extension[+].url = "http://ema.europa.eu/fhir/extension/marketing-authorization-holder"
* subject.extension[=].valueCoding = $100000000005#mah-code "None"
* subject.extension[+].url = "http://ema.europa.eu/fhir/extension/active-substance"
* subject.extension[=].valueCoding = $100000000005#acive-substance-code "None"
* subject.extension[+].url = "http://ema.europa.eu/fhir/extension/domain"
* subject.extension[=].valueCoding = $100000000004#100000000012 "H"

* date = "2015-02-07T13:28:17Z"


* entry
  * flag = urn:oid:1.2.36.1.2001.1001.101.104.16592#01
  * flag.text = "Unchanged"
  * date = "2015-02-07T13:28:17Z"
  * item = Reference(bundlepackageleaflet-en-c8b09940edf0aa917a934cf86ca85bbd) // spherox en
  * item.extension[0].url = "http://ema.europa.eu/fhir/extension/documentType"
  * item.extension[=].valueCoding = $100000155531#100000155538 "B. PACKAGE LEAFLET"
  * item.extension[+].url = "http://ema.europa.eu/fhir/extension/language"
  * item.extension[=].valueCoding = $100000072057#100000072147 "en"



* entry
  * flag = urn:oid:1.2.36.1.2001.1001.101.104.16592#01
  * flag.text = "Unchanged"
  * date = "2015-02-07T13:28:17Z"
  * item = Reference(bundlepackageleaflet-da-c8b09940edf0aa917a934cf86ca85bbd) // spherox da
  * item.extension[0].url = "http://ema.europa.eu/fhir/extension/documentType"
  * item.extension[=].valueCoding = $100000155531#100000155538 "B. PACKAGE LEAFLET"
  * item.extension[+].url = "http://ema.europa.eu/fhir/extension/language"
  * item.extension[=].valueCoding = $100000072057#100000072147 "da"




Instance: List-c8b09940edf0aa917a934cf86ca85bbd
InstanceOf: List

* insert c8b09940edf0aa917a934cf86ca85bbdListRuleset
    